Physician profile
Dean Barone
NPI 1013086818
$68,515.72
in general payments reported to CMS, 2019-2025
20 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27K · 2022: $17K · 2023: $11K · 2024: $2,904 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Food and Beverage: $1,738 · Travel and Lodging: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,425.98 |
| Food and Beverage | $1,738.05 |
| Travel and Lodging | $1,349.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $48,321.67 | 2021-2025 | Stratafix, Dermabond, Monocryl |
| Ethicon US, LLC | $17,898.09 | 2021-2025 | Stratafix, Dermabond, Pds |
| Medtronic, INC. | $478.86 | 2022-2025 | Percept Pc Brainsense, Inceptiv, Sensight |
| Ethicon INC. | $462.34 | 2021 | |
| Stryker Corporation | $307.17 | 2022 | |
| Intrinsic Therapeutics | $300.95 | 2025 | Barricaid Acd (Annular Closure Device) |
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2024 | Andexxa |
| Providence Medical Technology, INC. | $124.00 | 2024 | |
| Silk Road Medical, INC. | $101.56 | 2022 | |
| Gt Medical Technologies, INC | $90.41 | 2023 | Gammatile |
| Collegium Pharmaceutical, INC. | $69.62 | 2024-2025 | Belbuca |
| Si-Bone, INC. | $63.88 | 2022 | |
| Bone Support INC. | $42.12 | 2025 | Cerament G, Ceramentbone Void Filler |
| Depuy Synthes Sales INC. | $38.40 | 2023 | |
| Amneal Pharmaceuticals LLC | $16.78 | 2023 | Rytary |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Protega Pharmaceutials INC | $16.02 | 2023 | Roxybond |
| Averitas Pharma INC. | $15.76 | 2023 | Qutenza |
| Alexion Pharmaceuticals, INC. | $14.93 | 2021 | |
| Eisai INC. | $14.25 | 2023 | |
| Chiesi USA, INC. | $13.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Barone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.